To receive our monthly eNews as well as event notices and other updates, just enter your email address.
(Deadline: December 2, 2013)
The Lewis Rudin Glaucoma Prize of The New York Academy of Medicine was established in 1995 in honor of Lewis Rudin, the New York City real estate developer, and is funded by the May and Samuel Rudin Family Foundation with additional support provided by Mr. Jack Rudin.
This $50,000 prize is awarded for the most outstanding scholarly article on glaucoma published in a peer-reviewed journal during the previous calendar year. Nominations are solicited from leaders of the ophthalmologic community and solicited through notices in the Journal of Glaucoma and other publications.
One prize winner is recommended for ratification by the Academy’s Board of Trustees by the Lewis Rudin Glaucoma Prize Selection Committee, a group of nationally recognized experts in glaucoma research chaired by David H. Abramson, MD of Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University.
Nominees for this award must be the first or last author of the published work and must hold primary responsibility for the research. Authors may nominate themselves but may not submit multiple articles and must choose only one article to submit for consideration by the committee.
Please complete all relevant areas of the attached one-page nomination form. Questions or comments regarding the Lewis Rudin Glaucoma Prize, the instructions, or the nomination form, should be directed to the Office of Trustee and Fellowship Affairs of The New York Academy of Medicine.
Nomination materials must be submitted electronically by emailing the completed nomination form with an accompanying electronic copy of the published article as e-mail attachments to firstname.lastname@example.org.
Nominations must be received no later than Dec 2, 2013.
The prize winner will be announced within weeks of the submission deadline. All authors of the article receive recognition, however the monetary prize is granted solely to the primary researcher specified in the nomination.
By signing the above linked application, the applicant and their institution agree to the NYAM Patent Policy
Lewis Rudin Glaucoma Prize
Office of Sponsored Programs
The New York Academy of Medicine
1216 Fifth Avenue
New York, New York 10029
Tel: (212) 822-7204
Fax: (212) 822-7338
The mission of The New York Academy of Medicine is to advance the health of people in cities. Drawing on the expertise of diverse partners worldwide and more than 2,000 elected Fellows from across the professions, our current priorities are to create environments in cities that support healthy aging; to strengthen systems that prevent disease and promote the public's health; to eliminate health disparities; and preserve and promote the heritage of medicine and public health.
Instructions on how to apply for NYAM's research fellowships, student grants, endowed lectures and awards are contained within the description of each program. Please click on your program of interest for full details.
NYAM welcomed Michael A. Weber, MD to deliver the 2013 Nahum J. Winer Lecturer on October 8, 2013. Dr. Weber is Professor of Medicine at the SUNY Downstate College of Medicine in Brooklyn, New York. The topic of his lecture was “Unresolved Issues in Diagnosing and Treating Hypertension: Is Renal Sympathectomy An Answer?
Tom F. Lue, MD, FACS, was awarded the 2013 Ferdinand C. Valentine Award during a reception at NYAM on April 10, 2013. Dr. Lue is Professor and Vice-Chair of Urology, Emil Tanagho Endowed Chair in Clinical Urology, and Founder of the Knuppe Molecular Urology Laboratory at the University of California at San Francisco.
Jean L. Bolognia, MD, Professor of Dermatology, Vice Chair of Clinical Affairs, and Director of the Pigmented Lesion Clinic at Yale University School of Medicine, delivered the 2013 Howard Fox Memorial Lecture on April 26, 2013 at NYAM. The subject of her lecture, which was sponsored by the NYAM Section on Dermatology, was Signature Nevi. Patients who have an increased number of moles tend to be consistent in the type of mole they produce, and the repetitive type for a given patient is that patient’s signature nevus. Patients with numerous melanocytic nevi, i.e., those who are moley, often produce a particular type of nevus, a so-called signature nevus.